The effectiveness of extra corporeal shock wave therapy for plantar heel pain: a systematic review and meta-analysis

Table 5 Summary of most commonly reported outcomes measures at 12 weeks (or nearest point to). P values relate to active treatment versus placebo or reduced dose. * Indicates a statistical significant difference in favour of EWST treatment. Figures in parentheses are 95% confidence intervals. Where p-values were not provided, the values for mean and standard deviations [SD] are given, I indicates EWST group, II indicates placebo group. "Favours ESWT" indicates a better outcome for ESWT where neither of the previous details are provided.

Author	Morning/start up pain	Overall pain	Walking ability /activity related	Foot specific score	Pain at rest (100 mm VAS)	Pain on pressure	Night pain/evening pain	End point
Abt et al [21]	P = 0.016*	-	Favours ESWT	-	P = 0.01*	P = 0.26	P = 0.01*	19 weeks
Buch et al [27]	P = 0.0309	-	P = 0.7377	I. (49.1–71.5) II.(32.9–55.9) AOFAS	-	Not significant	P < 0.4338	12 weeks
Buchbinder et al [10]	P = 0.92 (-12.7 – 13.1)	P = 0.99 (-10.3–11.5)	P = 0.0.72 (0.6–1.9)	P = 0.85 (-7.6–5.3) Maryland FS	-	-	-	12 weeks
Cosentino et al [33]	P < 0.0001*	-	P < 0.0001*	-	P < 0.0001*	-	-	12 weeks
Haake et al [11]	I mean = 4.0, SD = 3.2 II mean = 4.5, SD = 3.0	-	Favours ESWT	-	I mean = 2.4, SD = 2.6 II mean = 2.4, SD = 2.5	I mean = 4.0, SD = 3.2 II mean = 4.3, SD = 3.2	I mean = 1.5, SD = 2.4 II mean = 1.8, SD = 2.5	12 weeks
Krischek et al [22]	-	Favours ESWT	Favours ESWT	-	-	Favours ESWT	-	12 weeks
Ogden et al [28]	Favours ESWT	-	-	-	-	Favours ESWT	-	12 weeks
Rompe et al [32]	-	-	Favours ESWT	-	P < 0.0001*	P < 0.0001*	P < 0.0001*	12 weeks
Rompe et al [30]	Favours ESWT	Favours ESWT	P < 0.0001*	-	P < 0.05*	P < 0.0001*	P < 0.05*	12 weeks
Rompe et al [31]	P = 0.0004*	-	-	P = 0.0025* AOFAS	-	-	-	26 weeks
Speed et al	P = 0.664 (0.656–1.271)	P = 0.246 (0.626–1.093)	-	-	-	-	P = 0.378 (0.620–1.166)	12 weeks

ISSN: 1471-2474